38 completed, 13 terminated, 3 withdrawn, 1 active not recruiting. 30 Phase 1, 22 Phase 2, 7 Not applicable, 1 Early Phase 1.
Follow Small Intestine Lymphoma: new trials by email Literature Review of Small Intestine Lymphoma trials Research Report on Small Intestine Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma rituximab, lenalidomide, romidepsin - B-cell Adult Acute Lymphoblastic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Phase 1 / Phase 2 | Withdrawn | Mayo Clinic | 2016-10-01 | 2016-08-11 | |
| Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma | Not applicable | Withdrawn | Fred Hutchinson Cancer Center | 2015-02-01 | 2015-05-07 | |
| CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma 6,8-bis(benzylthio)octanoic acid, bendamustine hydrochloride, rituximab - B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia | Phase 1 | Terminated | Wake Forest University Health Sciences | 1 | 2014-12-01 | 2018-07-02 |
| Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas lenalidomide, etoposide, prednisone - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | Completed | University of Chicago | 55 | 2014-07-29 | 2026-03-11 |
| Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant busulfan, etoposide, cyclophosphamide - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 33 | 2014-03-01 | 2015-08-13 |
| Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies cyclophosphamide, fludarabine phosphate, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 2 | Withdrawn | University of Medicine and Dentistry of New Jersey | 2014-01-01 | 2016-07-14 | |
| MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Morphotek | 27 | 2013-11-01 | 2016-01-08 |
| Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells, autologous hematopoietic stem cell transplantation, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma | Phase 1 | Active not recruiting | City of Hope Medical Center | 30 | 2013-10-08 | 2026-06-25 |
| Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies vorinostat, tacrolimus, cyclosporine - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission | Phase 2 | Completed | National Cancer Institute (NCI) | 12 | 2013-06-01 | 2018-07-24 |
| Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies therapeutic allogeneic lymphocytes, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 2 | Completed | University of Chicago | 77 | 2013-04-04 | 2019-08-07 |
| Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas brentuximab vedotin, rituximab, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 / Phase 2 | Terminated | Northwestern University | 20 | 2013-03-05 | 2021-09-01 |
| Ipilimumab and Local Radiation for Selected Solid Tumors Ipilimumab, Radiation therapy - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Terminated | Stanford University | 3 | 2013-02-01 | 2024-01-24 |
| Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant lenalidomide, rituximab, pharmacological study - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Terminated | Fred Hutchinson Cancer Center | 3 | 2012-05-01 | 2017-07-27 |
| Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma plerixafor, filgrastim, etoposide - Adult Acute Lymphoblastic Leukemia in Remission, Adult Grade III Lymphomatoid Granulomatosis | Not applicable | Terminated | Case Comprehensive Cancer Center | 25 | 2011-10-01 | 2019-06-14 |
| Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Fred Hutchinson Cancer Center | 43 | 2011-09-01 | 2017-05-19 |
| Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma bortezomib, filgrastim, autologous hematopoietic stem cell transplantation - Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 23 | 2011-07-01 | 2021-05-10 |
| Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies fludarabine phosphate, methoxyamine, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 20 | 2011-05-01 | 2015-08-13 |
| Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma panobinostat, laboratory biomarker analysis, western blotting - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Completed | Mayo Clinic | 41 | 2011-01-17 | 2022-05-24 |
| Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies deferasirox, laboratory biomarker analysis, enzyme-linked immunosorbent assay - Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Wake Forest University Health Sciences | 16 | 2011-01-01 | 2018-09-07 |
| MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Akt inhibitor MK2206, diagnostic laboratory biomarker analysis, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage | Phase 1 | Completed | National Cancer Institute (NCI) | 45 | 2011-01-01 | 2014-04-29 |
Showing 20 of 55. Sign in to see all of them.
Lymphoma, Large B-Cell, Diffuse (49) · Leukemia, Lymphocytic, Chronic, B-Cell (48) · Lymphoma, B-Cell, Marginal Zone (48) · Lymphoma, Follicular (48) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (48) · Lymphoma, Mantle-Cell (47) · Burkitt Lymphoma (46) · Intraocular Lymphoma (46) · Waldenstrom Macroglobulinemia (46) · Lymphoma, Non-Hodgkin (45) · Lymphoma, Large-Cell, Immunoblastic (44) · Lymphoma, Large-Cell, Anaplastic (43) · Mycosis Fungoides (43) · Sezary Syndrome (43) · Immunoblastic Lymphadenopathy (41)
Neoplasms (55) · Neoplasms by Histologic Type (55) · Hematologic Diseases (52) · Hemic and Lymphatic Diseases (52) · Immune System Diseases (52) · Immunoproliferative Disorders (52) · Lymphatic Diseases (52) · Lymphoproliferative Disorders (52) · Leukemia, Lymphoid (51) · Lymphoma (51) · Leukemia (50) · Lymphoma, B-Cell (50) · Disease Attributes (49) · Neoplasms by Site (49) · Pathologic Processes (49)
Peripheral Blood Stem Cell Transplantation (12) · Rituximab (9) · Whole-Body Irradiation (9) · fludarabine phosphate (9) · Cyclosporine (8) · Mycophenolic Acid (8) · Cyclophosphamide (6) · Etoposide (6) · Lenalidomide (4) · Tacrolimus (4) · Bortezomib (3) · Busulfan (3) · Filgrastim (3) · Flow Cytometry (3) · Granulocyte Colony-Stimulating Factor (3)
National Cancer Institute (NCI) (22) · Fred Hutchinson Cancer Center (13) · Case Comprehensive Cancer Center (4) · City of Hope Medical Center (3) · Mayo Clinic (2) · University of Chicago (2) · Wake Forest University Health Sciences (2) · Barbara Ann Karmanos Cancer Institute (1) · Morphotek (1) · Northwestern University (1) · Pierluigi Porcu (1) · Stanford University (1) · University of Medicine and Dentistry of New Jersey (1) · University of Washington (1)
United States (54) · Italy (5) · Canada (3) · Germany (2)
David Maloney (5) · Ajay Gopal (3) · Ann Woolfrey (2) · Ramesh Ramanathan (2) · Adam Petrich, MD (1) · Barbara Pro (1) · Brenda Sandmaier (1) · Brian Hill, MD (1) · David Hong (1) · Divaya Bhutani, M.D. (1) · Elizabeth Budde (1) · George A. Fisher, MD, PhD (1) · George Wilding (1) · Grzegorz Nowakowski (1) · Hillard Lazarus (1)
PMID 32499241, PMID 18698002, PMID 23256542, PMID 23393050, PMID 26213141, PMID 26764356, PMID 27118452, PMID 29292843, PMID 31481800, PMID 34515338, PMID 40720747
P30CA015704 (11), U01CA062491 (4), P01CA078902 (3), U01CA062487 (3), U01CA097452 (3), U01CA099168 (3), N01CM62202 (2), P01CA018029 (2), P30CA015083 (2), P30CA016672 (2), P30CA022453 (2), P30CA043703 (2), P50CA107399 (2), U01CA062505 (2), U01CA076576 (2)